Valneva SE
VALN- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001836564
No open-market purchases or sales by Valneva SE insiders were filed in the last 90 days; 20 institutions reported holding it in 13F filings for Q2 2026, worth $19.8M in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Valneva SE as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- +2 vs. Q4 2025
- Shares held
- 3.91M
- −1.29M (−24.8%) vs. Q4 2025
- Total value
- $24.4M
- −$21.4M (−46.7%) vs. Q4 2025
- New holders
- 5
- 3 more added
- Sold out
- 3
- 5 more reduced
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VALN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 20 | $19.8M |
| Q1 2026 | 21 | $24.4M |
| Q4 2025 | 19 | $45.8M |
| Q3 2025 | 18 | $64.3M |
| Q2 2025 | 18 | $25.6M |
| Q1 2025 | 14 | $4.53M |
| Q4 2024 | 12 | $3.16M |
| Q3 2024 | 10 | $4.35M |
| Q2 2024 | 11 | $4.73M |
| Q1 2024 | 11 | $3.60M |
| Q4 2023 | 9 | $3.98M |
| Q3 2023 | 10 | $4.69M |
| Q2 2023 | 11 | $5.55M |
| Q1 2023 | 11 | $4.27M |
| Q4 2022 | 10 | $5.16M |
| Q3 2022 | 11 | $4.36M |
| Q2 2022 | 9 | $1.40M |
| Q1 2022 | 11 | $4.70M |
| Q4 2021 | 10 | $6.43M |
| Q3 2021 | 8 | $8.27M |
| Q2 2021 | 9 | $21.1M |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Valneva SE; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Activest Wealth Management | 1 | $6 | 0.00% | 00.0% | Unchanged |
| Allworth Financial LP | 7 | $44 | 0.00% | 00.0% | Unchanged |
| Smartleaf Asset Management LLC | 43 | $266 | 0.00% | 00.0% | Unchanged |
| Clearstead Advisors, LLC | 48 | $303 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 55 | $344 | 0.00% | −1,500−96.5% | Reduced |
| EverSource Wealth Advisors, LLC | 91 | $569 | 0.00% | −7−7.1% | Reduced |
| BNP Paribas Arbitrage, SA | 200 | $1.25K | 0.00% | +200 | New |
| UBS Group AG | 782 | $4.89K | 0.00% | +579+285.2% | Added |
| Steigerwald, Gordon & Koch Inc. | 1,250 | $7.81K | 0.00% | +1,250 | New |
| GAMMA Investing LLC | 1,426 | $8.91K | 0.00% | −431−23.2% | Reduced |
| Rhumbline Advisers | 1,793 | $11.2K | 0.00% | +30+1.7% | Added |
| China Universal Asset Management Co., Ltd. | 5,000 | $31.3K | 0.00% | 00.0% | Unchanged |
| VSM Wealth Advisory, LLC | 10,000 | $62.5K | 0.02% | +10,000 | New |
| Old Mission Capital LLC | 13,759 | $86.0K | 0.00% | +13,759 | New |
| HRT Financial LP | 20,847 | $130.0K | 0.00% | +20,847 | New |
| Ironwood Investment Management LLC | 25,135 | $157.1K | 0.07% | 00.0% | Unchanged |
| Morgan Stanley | 46,925 | $293.3K | 0.00% | +3,944+9.2% | Added |
| Wells Fargo & Company | 78,029 | $487.7K | 0.00% | −45,434−36.8% | Reduced |
| General American Investors Co Inc | 354,361 | $2.21M | 0.15% | 00.0% | Unchanged |
| Novo Holdings A/S | 1,057,421 | $6.61M | 0.54% | −1,247,579−54.1% | Reduced |
| Frazier Life Sciences Management, L.P. | 2,291,666 | $14.3M | 0.37% | 00.0% | Unchanged |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −23,494−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −10,634−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −9,396−100.0% | Sold out |